Couling John D 4

What Happened

• John D. Couling, Senior Vice President, Entertainment at Dolby Laboratories, exercised stock options to acquire 7,666 shares at an exercise price of $45.50 (total cost $348,803) on 2026-06-01. On the same date he sold those 7,666 shares in open-market transactions for aggregate proceeds of approximately $426,419. The exercise option was fully vested as of the transaction date.

Key Details

• Transaction date: 2026-06-01; Form 4 filed 2026-06-03 (timely).
• Option exercise (code M): 7,666 shares acquired at $45.50 each — $348,803 total.
• Open-market sales (code S): 7,158 shares @ $55.59 and 508 shares @ $56.16; total proceeds ~$426,419 (weighted avg ≈ $55.63). Sales executed under a 10b5-1 trading plan adopted Feb 3, 2026 (footnote F3). Prices across trades ranged $55.15–$56.105.
• Shares held after the transactions: filing notes inclusion of 55,114 shares underlying restricted stock units (subject to forfeiture until vesting) and 374 shares acquired under the issuer’s ESPP (May 15, 2026). Total reported outstanding shares after the transactions are not explicitly tallied in the filing.
• Option background: The option grant covered 46,000 shares in total; the exercised portion was fully vested (footnote F4).
• The filing includes an undertaking to provide detailed per-trade info upon request (footnote F3).

Context

• This was an exercise of vested options followed by immediate sale of the acquired shares (a cashless exercise pattern). Sales executed via a pre-established 10b5-1 plan, which typically indicates trades were automated under a plan rather than ad hoc decisions.
• Purchases (options exercised) and subsequent sales are routine forms of insider liquidity and do not by themselves indicate a change in company outlook. The filing is factual and timely.